MTOR and type 2 diabetes mellitus: Moreover, multiple signaling pathways are involved in the etiology of T2DM, including adenosine monophosphate-activated protein kinase/sirtuin (AMPK/SIRT1) and adenosine monophosphate-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) [13].